Literature DB >> 8566018

Interleukin-4-producing CD4+ NK1.1+ TCR alpha/beta intermediate liver lymphocytes are down-regulated by Listeria monocytogenes.

M Emoto1, Y Emoto, S H Kaufmann.   

Abstract

Experimental infection of mice with the intracellular bacterium, Listeria monocytogenes, provides a paragon model for immune defence dominated by T helper type 1 (Th1) responses. Potent production of interleukin (IL)-12 by infected macrophages is considered the determining factor in Th1 cell development. In contrast, it is assumed that IL-4 producers remain virtually unstimulated in listeriosis. In the liver, the major target organ of listeriosis, an unusual T lymphocyte population exists with the intriguing phenotype CD4+ NK1.1+ TCR alpha/beta intermediate (TCR alpha/beta int). Here we show that IL-4-producing CD4+ NK1.1+ TCR alpha/beta int liver lymphocytes are down-regulated early in listeriosis. We assume that curtailment of IL-4-producing CD4+ NK1.1+ TCR alpha/beta int liver lymphocytes promotes unconstrained development of Th1 cells which are central to protection against intracellular bacteria.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566018     DOI: 10.1002/eji.1830251218

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.

Authors:  Michael T Wilson; Cecilia Johansson; Danyvid Olivares-Villagómez; Avneesh K Singh; Aleksandar K Stanic; Chyung-Ru Wang; Sebastian Joyce; Mary Jo Wick; Luc Van Kaer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

Review 2.  Regulation of immune responses by CD1d-restricted natural killer T cells.

Authors:  Luc Van Kaer
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Immune evasion of the CD1d/NKT cell axis.

Authors:  Randy R Brutkiewicz; Laura Yunes-Medina; Jianyun Liu
Journal:  Curr Opin Immunol       Date:  2018-05-04       Impact factor: 7.486

4.  Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activation.

Authors:  Masashi Emoto; Tomomi Yoshida; Toshio Fukuda; Ikuo Kawamura; Masao Mitsuyama; Eiji Kita; Robert Hurwitz; Stefan H E Kaufmann; Yoshiko Emoto
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

5.  Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression.

Authors:  P M Spence; V Sriram; L Van Kaer; J A Hobbs; R R Brutkiewicz
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

6.  Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling.

Authors:  Masashi Emoto; Takamitsu Shimizu; Hiromi Koike; Izumi Yoshizawa; Robert Hurwitz; Stefan H E Kaufmann; Yoshiko Emoto
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

7.  Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection.

Authors:  Masashi Emoto; Izumi Yoshizawa; Yoshiko Emoto; Mamiko Miamoto; Robert Hurwitz; Stefan H E Kaufmann
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

8.  Comparison of intrahepatic lymphocytes from normal and growth hormone transgenic mice with chronic hepatitis and liver cancer.

Authors:  C L Hardy; P S Bhathal; K J Snibson; T E Adams
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

9.  Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.

Authors:  J A Hobbs; S Cho; T J Roberts; V Sriram; J Zhang; M Xu; R R Brutkiewicz
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.

Authors:  Yoshiko Habu; Takefumi Uchida; Takuo Inui; Hiroyuki Nakashima; Masashi Fukasawa; Shuhji Seki
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.